Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000146106 | SCV000193323 | uncertain significance | Diabetes mellitus | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000665154 | SCV000789223 | uncertain significance | Permanent neonatal diabetes mellitus; Diabetes mellitus, transient neonatal, 3; Hyperinsulinemic hypoglycemia, familial, 2 | 2017-01-19 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002227074 | SCV002506461 | uncertain significance | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which may be responsive to oral sulfonylureas. It is also associated with Neonatal Diabetes.However, this particular variant (rs587783668) association with MODY remains uncertain. More studies are required to ascertain its role in MODY. | |
Fulgent Genetics, |
RCV002483282 | SCV002786379 | uncertain significance | Diabetes mellitus, transient neonatal, 3; Hyperinsulinemic hypoglycemia, familial, 2; Type 2 diabetes mellitus; Maturity-onset diabetes of the young type 13; Diabetes mellitus, permanent neonatal 2 | 2021-07-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002514817 | SCV003516446 | uncertain significance | not provided | 2021-09-24 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with methionine at codon 155 of the KCNJ11 protein (p.Val155Met). The valine residue is highly conserved and there is a small physicochemical difference between valine and methionine. This variant is present in population databases (rs587783668, ExAC 0.002%). This variant has not been reported in the literature in individuals with KCNJ11-related conditions. ClinVar contains an entry for this variant (Variation ID: 158675). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001277850 | SCV001464829 | uncertain significance | Permanent neonatal diabetes mellitus | 2020-04-13 | no assertion criteria provided | clinical testing |